Method for screening patient-specific anti-cancer agent using limiting dilution assay

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9562891
APP PUB NO 20150101070A1
SERIAL NO

14228205

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A screening method is described for selecting patient-specific anti-cancer agents reflecting individual genetic properties, in a precise and rapid manner, using an extremely small amount of cancer cells. Such screening method is useful for development of novel anti-cancer agents and the personalized medical field.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SAMSUNG LIFE PUBLIC WELFARE FOUNDATIONSEOUL 140-893

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choi, YeonSook Seoul, KR 1 6
Joo, Kyeung Min Seoul, KR 10 22
Nam, Do Hyun Seoul, KR 36 80

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00